This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Flamma S.p.a.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Minyu Zheng: Innovator in Pharmaceutical Synthesis
Introduction
Minyu Zheng is a notable inventor based in Dalian, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of active ingredients for medical therapies. With a total of two patents to his name, Zheng's work is focused on addressing both common and rare diseases.
Latest Patents
Zheng's latest patents include a process for preparing D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide. This invention relates to a solution-phase synthesis of the compound, which serves as an active ingredient used in mitochondrial targeted therapy for ischemia reperfusion injury. His second patent also pertains to the production of the same compound, emphasizing its importance in medical applications.
Career Highlights
Minyu Zheng is currently associated with Flamma S.p.a., where he continues to innovate in the pharmaceutical sector. His expertise in synthesis processes has positioned him as a valuable asset in the development of therapeutic solutions.
Collaborations
Zheng collaborates with talented coworkers, including Xinjun Zhao and Xiaozhong Yu, who contribute to his research and development efforts.
Conclusion
Minyu Zheng's work in pharmaceutical synthesis showcases his dedication to advancing medical therapies through innovative processes. His contributions are vital in the ongoing fight against various diseases, highlighting the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile